SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is trending following the official announcement that the stock will be added to the S&P 500, a milestone that has triggered significant after-hours price appreciation and widespread community debate. Investors are actively discussing the potential impact of index fund buying, with many debating whether the inclusion acts as a sustainable momentum catalyst or a signal for a short-term 'sell the news' fade.

Applied Materials, Inc. engages in provision of materials engineering solutions used to produce semiconductors. The firm also focuses on design, development, production, and servicing of the critical wafer fabrication tools used for customers to manufacture semiconductors. It operates through the following segments: Semiconductor Systems and Applied Global Services (AGS). The Semiconductor Systems segment includes designing, development, manufacturing and sale of equipment used to fabricate semiconductor chips referred to as integrated circuits. The AGS segment engages in provision of services, spares, and factory automation software to customer fabrication plants globally. The company was founded on November 10, 1967 and is headquartered in Santa Clara, CA.

Applied Materials Inc.

Applied Materials is currently trending as investors weigh strong AI-driven infrastructure demand against broader sector volatility and profit-taking in semiconductor equipment stocks. Market participants are intensely debating whether the recent price drawdown represents a temporary consolidation or a sign that elevated growth expectations are already fully priced into the shares.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is seeing a wave of bullish sentiment driven by significant insider accumulation, with multiple executives, including the CEO, making major open-market purchases as the stock trades at multi-year lows. Investors are actively debating whether this cluster of insider buying and recent technical support levels signal a definitive long-term bottom, despite ongoing volatility and concerns surrounding procedure volume growth.

Nu Holdings Ltd. is a holding company, which engages in the provision of digital banking services. The company was founded by David Vélez Osorno, Cristina Helena Zingaretti Junqueira, and Adam Edward Wible on February 26, 2016 and is headquartered in São Paulo, Brazil.

Nu Holdings Ltd - Ordinary Shares Class A

Nu Holdings Ltd

Nu Holdings is facing downward price pressure following a downgrade by Bank of America citing management transition concerns and credit quality, despite the company's recent announcement of a one billion dollar share repurchase program. The community is actively discussing the stock's long-term growth potential and international expansion efforts, with many viewing the current price dip as an accumulation opportunity while labeling the analyst downgrade as an overreaction.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining strong market momentum as investors closely monitor progress toward a fourth-quarter Biologics License Application filing, with the community highlighting successful manufacturing alignment with the FDA as a major de-risking catalyst. Bullish sentiment is further bolstered by accelerating institutional accumulation, positive clinical trial data, and community speculation surrounding potential buyout interest from major pharmaceutical players.

TSS, Inc. engages in the provision of comprehensive services for the planning, design, development and maintenance of mission-critical facilities and information infrastructure as well as integration services. It operates through the Facilities and Systems Integration Services business segments. The Facilities segment consists of the design, project management, and maintenance of data center and mission-critical business operations. The Systems Integration segment integrates information technology equipment for original equipment manufacturer vendors and customers to be used inside data center environments, including modular data centers. The company was founded by Gerard J. Gallagher on December 20, 2004 and is headquartered in Georgetown, TX.

TSS Inc

TSS Inc. is seeing intense community debate following recent earnings, with investors divided between those betting on long-term AI infrastructure growth and those concerned by customer concentration risks and disappointing revenue trends. While some market participants see potential in the company's shift toward high-margin AI systems integration and new leadership, others are actively shorting the stock, citing a lack of significant new customer diversification and sluggish execution.

York Space Systems, Inc. engages in providing a comprehensive suite of mission-critical solutions for national security, government, and commercial customers. It offers a vertically integrated, full technology stack of solutions including design, production, integration, and operation of spacecraft with turnkey offerings to manage spacecraft and constellations throughout the entire mission lifecycle. The company was founded by Dirk Wallinger in January 2012 and is headquartered in Denver, CO.

York Space Systems Inc

York Space Systems is drawing significant investor interest following its recent Q2 earnings report and a sharp after-hours price decline, which has triggered debates over the company's lowered fiscal guidance and the departure of its CFO. While some investors are treating the volatility as a buying opportunity given the firm's defense-focused backlog, others are expressing caution due to high dilution, institutional selling, and ongoing skepticism regarding management's ability to navigate competitive procurement cycles.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is surging as investors closely monitor the drone sector for anticipated government contract awards and increased domestic defense spending. The community is actively discussing the company's strategic manufacturing expansion and its role as an NDAA-compliant supplier, with many speculating on the impact of future federal equity stakes or procurement deals on the stock's long-term trajectory.

ARS Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on the development of a novel, potentially first-in-class product candidate, neffy, for the emergency treatment of Type I allergic reactions including anaphylaxis. Its product includes Epinephrine Nasal Spray. The company was founded by Richard Lowenthal, Robert Bell, and Sarina Tanimoto on August 5, 2015 and is headquartered in San Diego, CA.

ARS Pharmaceuticals Inc

ARS Pharmaceuticals is experiencing significant volatility and downward pressure as investors react to the company's high cash burn rate and underwhelming commercial performance. The community is actively debating the stock's future, with many retail investors expressing frustration over management, while others closely watch for potential institutional shifts and the impact of looming competition.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOne is gaining significant investor attention due to its status as a highly undervalued cybersecurity pure-play, with many market participants viewing its current valuation as a prime setup for a major tech acquisition or a significant valuation re-rate. Community discussions are heavily centered on the company's superior balance sheet, strategic AI integration, and the potential windfall from its equity stake in Anthropic as a key catalyst for long-term upside.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$MSOS buy the underlyings these 3 will uplist soon $GTBIF $TRLV $CURLF thank me later

Elake

GenZinvestor561

mick lockwood

Rob D

Mikey

The Real Mc Coy

Ryan

Faqers

CopiousCope

Yes sir

colorama

Robert George

CasinosOfferFreeDrinks

$CURLF $GTBIF $MSOS $TRLV CURALEAF can’t uplist until around September. Has to wait 90 days if I’m not mistaken… what’s your estimation?

StockTwits for iOS

AdvisorShares Pure US Cannabis ETF

Green Thumb Industries

Trulieve Cannabis Corp 

Curaleaf Holdings Inc

 buy the underlyings these 3 will uplist soon 

@thepalace2007 i agree with buying the underlying names vs the ETF. Once in the underlying names purchase should be about outperformance not simply buying the three biggest names in the ETF. For me i own two names $TRLV and $JUSHF. TCNNF to help capture the first move from uplisting and Institusional flow. JUSHF to capture the second move particularly if we get Rec passed in Virginia and P.A. For the record i still think  there is a better than 50% chance VA gets green lit  as part of the budget process and if memory served me correct that should happen by July 1.

StockTwits Web

Jushi Holdings Inc

 i agree with buying the underlying names vs the ETF. Once in the underlying names purchase should be about outperformance not simply buying the three biggest names in the ETF. For me i own two names $TCNNF and 

. TCNNF to help capture the first move from uplisting and Institusional flow. JUSHF to capture the second move particularly if we get Rec passed in Virginia and P.A. For the record i still think  there is a better than 50% chance VA gets green lit  as part of the budget process and if memory served me correct that should happen by July 1.

Scott Bere

@Sb123321 I just bought a little $VRNO today too 10k @1.15

El Gordo

Verano Holdings Corp.

@thepalace2007 i will need to take another look there. i owned it for awhile in 2023 but sold it jan of 24 to buy TCNNF and JUSHF. Up alot on TCNNF (100%) and a bit on JUSHF (12%) while VRNOF dropped 70-75% over the same period. i guess given the significant under preformance it may be worth a second look.

 i will need to take another look there. i owned it for awhile in 2023 but sold it jan of 24 to buy TCNNF and JUSHF. Up alot on TCNNF (100%) and a bit on JUSHF (12%) while VRNOF dropped 70-75% over the same period. i guess given the significant under preformance it may be worth a second look.

@thepalace2007 only $tcnnf is able to uplist before hearing.  others will be later, 2nd &amp; 3rd wave.

 only $tcnnf is able to uplist before hearing.  others will be later, 2nd & 3rd wave.